Exhibition

COVID19+9G test(TM)

COVID19+9G test(TM)


Negotiable Min Order Quantity Unit

Required Quantity
Place of Origin
South Korea
Payment Terms
Negotiable
Production method
Negotiable
Shipping / Lead Time
Negotiable / Negotiable
Keyword
diagnostic kit, covid19
Category
Medical Test Kit

Biometrix Technology Co, Ltd

Country / Year Established
South Korea South Korea / 2000
Business type
Manufacturer
Verified Certificate

4

DUNS

GMP

ISO

Product name COVID19+9G test(TM) Certification -
Category Medical Test Kit Ingredients -
Keyword diagnostic kit , covid19 Unit Size -
Brand name - Unit Weigh -
origin South Korea Stock -
Supply type - HS code -

Product Information

Why our kit takes unique position in the market? Wondering why our products have caught MOH’s interests from each country? We are proud to inform you that our COVID19+ 9G test™ LoD capacity covers 10 copies per test, and this provides BMT the unparalleled stance in the current diagnostic kit market.


Here are the other features you might want to take a look for our product:

 

- N gene, ORF3a gene, and RdRp gene are distinct genes identified only in COVID-19.

- E gene is a gene found in other corona family viruses as well.

- LoD of The COVID19+ 9G test™ 10 copies/test.

- LoD of 10 copies/test and 10^2 copies/sample-> not only allows the accurate detection of COVID-19

but also enables this test to detect recurrence earlier.

 

For much further details/clarifications, kindly reach us and we will be happy to be connected with you.

 

 

B2B Trade

Price (FOB) Negotiable transportation -
MOQ Negotiable Leadtime Negotiable
Payment Options Negotiable Shipping time Negotiable

Biometrix Technology Co, Ltd

Country / Year Established
South Korea South Korea / 2000
Business type
Manufacturer

4

DUNS

GMP

ISO

President
KIM TAE SEON
Address
Soyanggangro 56 Bioventureplaza 2 2 ho , Chuncheon-si, Gangwon-do, Korea
Product Category
Medical Test Kit,Other Monitoring & Diagnostic Equipment
Year Established
2000
No. of Total Employees
1-50
Company introduction

Biometrix Technology. Inc. has developed the world’s first 9G technology that arranges 9 guanine bases at regular intervals in a molecular recognition format and DAGON technology that can detect marker proteins up to a pg/ml level. Based on this core technology, we have established a platform technology applicable to the detection of various genes and proteins, and based on this, we sell IVD diagnostic devices and reagents. Using this technology, Biometrix Technology has entered into the market for cardiovascular disease prevention and management by using cardiovascular monitoring products to easily manage cardiovascular diseases. In addition, we are working hard to lead the field of early cancer screening molecular diagnostics that no one has entered the market yet. Biometrix Technology continues to showcase the world’s leading cardiovascular and early-stage cancer molecular diagnostic reagents and hopes to become the world’s leading professional healthcare company.

Main Product

Related Products

Other buyers also search

Membership Grade

BUYER

Biz Pro VIP

SELLER

Biz Pro VIP
팝업닫기
Live Chat A new message arrives
from a business partner.

No Data

  • There is no data to load
  • Check out the My TK > My Inquiries list.
  • After agreeing to the use of the Live Chat service, the list is printed only when there is at least one history of receiving or sending a Live Chat request.

If you have not yet agreed to use the Live Chat service,

You can use the Live Chat freely after agreeing to the use of the Live Chat service.

View more
View more